Skip to content

EV / EBITDA at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
21.3×-3.5×
FactSet Research Systems logo
FactSet Research SystemsFDS
10.7×-11.7×
Novanta logo
NovantaNOVT
27.1×-1.3×
BWX Technologies logo
BWX TechnologiesBWXT
38.3×+16.8×
Ralliant Corporation logo
Ralliant CorporationRAL
18.8×
Charles River Laboratories logo
Charles River LaboratoriesCRL
16.2×+2.9×

Other financials

Income statement

See full
Revenue$257.6M+27.5%
Gross profit$119.1M+23.9%
Operating income$3.7M-57.5%
Net income-$3.4M-1,233%
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$400.8M+115%
Total debt$478.3M-33.5%
Total equity$1.8B+22.2%
Total assets$3.5B+34.7%

Cash flow

See full
Operating cash flow$18.9M-46.9%
CapEx$9.5M+11.8%
Free cash flow$9.4M-65.3%

Valuation

See full
Market cap$4.55B+35.0%
Enterprise value$4.63B+18.5%
P/E181.4×
P/S4.6×+0.8×

Profitability

See full
Gross margin47.1%+0.1pp
Operating margin4.7%+0.3pp
Net margin2.6%
FCF margin9.1%-0.6pp

Returns & leverage

See full
Return on equity1.5%
Debt / equity0.3×-0.2×
Current ratio3.2×+1.0×

Where this comes from

Calculated from Mirion Technologies’s reported figures.

Based on the most recent quarter.

The official record: Mirion Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirion Technologies's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirion Technologies's EV / EBITDA?
Mirion Technologies (MIR) reported EV / EBITDA of 24.1× in Q1 2026.
How has Mirion Technologies's EV / EBITDA changed year-over-year?
Mirion Technologies's EV / EBITDA increased by 13.6% year-over-year, from 21.2× to 24.1×.
What is the long-term trend for Mirion Technologies's EV / EBITDA?
Over 3 years (2021 to 2025), Mirion Technologies's EV / EBITDA has grown at a -6.5% compound annual growth rate (CAGR), from 37.4× to 30.5×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.